HR(+) 乳腺癌对 CDK4/6 抑制剂耐药的免疫学机制
An immunological mechanism of resistance to CDK4/6 inhibitors in HR(+) breast cancer.
肿瘤细胞治疗研究
FRONTIER PAPERS
近 5 年肿瘤细胞治疗领域的研究论文。默认按评分排序(权威性 + 新鲜度)。
An immunological mechanism of resistance to CDK4/6 inhibitors in HR(+) breast cancer.
共 1 条
MEMBER ACCOUNT
登录成功会直接打开下一页。